JPH05310597A - Agent for contact treatment - Google Patents

Agent for contact treatment

Info

Publication number
JPH05310597A
JPH05310597A JP11183592A JP11183592A JPH05310597A JP H05310597 A JPH05310597 A JP H05310597A JP 11183592 A JP11183592 A JP 11183592A JP 11183592 A JP11183592 A JP 11183592A JP H05310597 A JPH05310597 A JP H05310597A
Authority
JP
Japan
Prior art keywords
skin
compound
electron
molecule
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11183592A
Other languages
Japanese (ja)
Other versions
JP2540691B2 (en
Inventor
Saburo Ishiguro
三郎 石黒
Tatsuo Inoue
達夫 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Furukawa Co Ltd
Original Assignee
Furukawa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Furukawa Co Ltd filed Critical Furukawa Co Ltd
Priority to JP4111835A priority Critical patent/JP2540691B2/en
Publication of JPH05310597A publication Critical patent/JPH05310597A/en
Application granted granted Critical
Publication of JP2540691B2 publication Critical patent/JP2540691B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE:To provide a contact treatment agent composed of a compound having electron-accepting structure in the molecule and allowable to be contacted with the surface of human skin, capable of absorbing abnormal potential on the skin, effective for the treatment of muscle ache, shoulder discomfort, etc., effective for wrinkle smoothing, hair growing, etc., and used by contacting with the skin. CONSTITUTION:The objective contact treatment agent is effective in absorbing abnormal potential to eliminate the ache by contacting with the skin, increasing the blood flow rate to eliminate the substance causative of ache and the fatigue substance retained in the capillary vessel and removing the pain and fatigue. The agent can be produced by using quinone, furan, furfural, pyrrole, thiophene, phthalocyanine, chlorophyll, hemoglobin, hemocyanine or their derivatives as a compound having electron accepting structure in the molecule and, for example, kneading the compound in an electrically conductive plastic and applying to the skin as a plaster, compounding the compound in an ointment, poultice, cream, pack, rinse, hair liquid or pomade or using as a component of a bathing agent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、筋肉痛、肩こり等の治
療、及び皺とり、育毛などのために、皮膚に接触して使
用される接触治療剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a contact therapeutic agent which is used in contact with the skin for the treatment of muscle pain, stiff shoulders, wrinkles, hair growth and the like.

【0002】[0002]

【従来の技術】従来、筋肉痛、肩こり等の治療には、鍼
治療の他に、電気治療器、磁気治療器、半導体治療器等
が使用されている。
2. Description of the Related Art Conventionally, in order to treat muscle pain, stiff shoulders, etc., in addition to acupuncture, an electric treatment device, a magnetic treatment device, a semiconductor treatment device, etc. have been used.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、電気治
療器、磁気治療器、半導体治療器等は、何れも成形体を
プラスター等で皮膚に固定するものであるため、押圧刺
激が大きすぎ、プラスターにかぶれるおそれがあり、見
た目が悪いという問題があった。本発明は、筋肉痛、肩
こり等の治療器におけるかかる問題を解決するものであ
って、治療効果が良く、筋肉痛、肩こり等の治療に加
え、皺とり、育毛などにも有効で、簡単に目立たない状
態で使用できる接触治療剤を提供することを目的とす
る。
However, since all of the electric treatment device, the magnetic treatment device, the semiconductor treatment device and the like fix the molded body to the skin with plaster or the like, the pressing stimulus is too large and the plaster is applied to the plaster. There was a risk of rashes, and there was the problem that it looked bad. The present invention is to solve such a problem in a therapeutic device for muscle pain, stiff shoulder, etc., and has a good therapeutic effect, in addition to the treatment of muscle pain, stiff shoulder, etc., it is also effective for wrinkle removal, hair growth, etc. It is an object to provide a contact therapeutic agent that can be used in a discreet state.

【0004】[0004]

【課題を解決するための手段】通常、人間の表皮の表側
は負に裏側は正に分極しており、p形半導体を皮膚の異
常電位を起こしている箇所に接触させると、表側の負の
異常電位を吸収して痛みが解消される。また、サーモグ
ラフィやレーザスペックル血流計を用いた測定によれ
ば、半導体を皮膚に接触させると血流が増加することが
認められる。血流が増加すれば、毛細血管に滞留してい
た痛みの原因物質や疲労物質が除去されるので、筋肉痛
や凝りが解消するものと考えられる。半導体にはp形半
導体とn形半導体とがあり、p形とn形の粉末状の半導
体を皮膚に塗布して筋肉痛などの治療試験を行なうと、
p形半導体に顕著な効果が認められる。粉末状のp形半
導体は、従来の半導体治療器では困難であった皺とりや
育毛にも利用できる。
[Means for Solving the Problems] Normally, the front side of human epidermis is negatively polarized and the back side is positively polarized. When a p-type semiconductor is brought into contact with a portion of skin where an abnormal potential is generated, Abnormal potential is absorbed and pain is resolved. Further, according to the measurement using a thermography or a laser speckle blood flow meter, it is recognized that the blood flow is increased when the semiconductor is brought into contact with the skin. It is considered that if the blood flow is increased, the pain-causing substance and the fatigue substance accumulated in the capillaries are removed, so that muscle pain and stiffness are eliminated. Semiconductors include p-type semiconductors and n-type semiconductors, and when p-type and n-type powdery semiconductors are applied to the skin and a therapeutic test for muscle pain is performed,
A remarkable effect is recognized in the p-type semiconductor. The powdery p-type semiconductor can also be used for wrinkle removal and hair growth, which have been difficult with conventional semiconductor treatment devices.

【0005】本発明者は、分子内に電子受容構造を有す
る化合物を用いて同様な試験を行ったところ、p形半導
体と同様の効果があることを発見した。電子受容構造と
は、相手から電子を受容し易い原子、分子、またはイオ
ンの構造をいい、例えば、ハイドロキノンと図1に示す
ようなベンゾキノンとの間の分子間化合物、所謂キンヒ
ドロンでは、ハイドロキノンが電子を供与し、ベンゾキ
ノンが電子を受容する。このような電子受容構造を有す
る電子受容体としては、沃素などのハロゲン、種々のキ
ノン類、トリニトロベンゼンなどが知られている。これ
らの電子受容体は、身体に密着するとp形半導体と同様
に体表面の異常の負電位を受容するため、筋肉を活性化
する。
The present inventor has conducted similar tests using a compound having an electron accepting structure in the molecule, and has found that it has the same effect as a p-type semiconductor. The electron-accepting structure refers to a structure of an atom, molecule, or ion that easily accepts an electron from the other party. For example, in a so-called quinhydrone, which is an intermolecular compound between hydroquinone and benzoquinone, hydroquinone is an electron. And benzoquinone accepts an electron. As an electron acceptor having such an electron accepting structure, halogen such as iodine, various quinones, trinitrobenzene and the like are known. When these electron acceptors come into close contact with the body, they receive an abnormal negative potential on the body surface like the p-type semiconductor, and thus activate muscles.

【0006】本発明は、上記知見に基づいてなされたも
のであって、接触治療剤を人体の皮膚表面に接触可能
で、分子内に電子受容構造を有する化合物で構成するこ
とにより前記課題を解決している。分子内に電子受容構
造を有する化合物としては、キノンの他、図2に示すよ
うなフラン〔図2(A)〕、フルフラール〔図2
(B)〕、ピロール〔図2(C)〕、チオフェン〔図2
(D)〕、フタロシアニン〔図2(E,F)〕がある。
天然の分子内に電子受容構造を有する化合物としては、
クロロフィル、ヘモグロビン、ヘモシアニンのようにポ
ルフィリン環を持つ化合物がある。ポルフィリン環は、
図3(A)に示すように、ピロール4個を〔=CH
2 −〕で結んだ環状構造を有しており、その中にMg,
Fe,Cuなどの金属が結合してクロロフィル〔図3
(B)〕、ヘモグロビン〔図3(C)〕、ヘモシアニン
(図示略)を形成する。これを電子的に見ると、ポルフ
ィリン環が電子受容体、Mg,Fe,Cuなどの金属が
電子供与体となっており、同一分子内に電子受容体と電
子供与体とが共存する形となるが、この場合も上記効果
は十分実現される。これは、電子供与体が皮膚に接触す
る部分では、電子供与体は皮膚表面の負の電気に対し無
反応であるので、電子受容体が皮膚に接触する部分があ
れば上記効果が得られるからである。従って、分子内に
電子受容構造を有する化合物であれば、電子供与構造を
有する化合物と共存してもよい。
The present invention has been made based on the above findings, and solves the above-mentioned problems by composing a contact therapeutic agent with a compound capable of contacting the skin surface of the human body and having an electron accepting structure in the molecule. is doing. As compounds having an electron accepting structure in the molecule, in addition to quinone, furan [Fig. 2 (A)] and furfural [Fig.
(B)], pyrrole [Fig. 2 (C)], thiophene [Fig. 2]
(D)] and phthalocyanine [Fig. 2 (E, F)].
As a compound having an electron accepting structure in a natural molecule,
Some compounds have a porphyrin ring, such as chlorophyll, hemoglobin, and hemocyanin. The porphyrin ring is
As shown in FIG. 3 (A), four pyrroles are [= CH
2− ] has a ring structure connected to each other, in which Mg,
Metals such as Fe and Cu combine to form chlorophyll [Fig.
(B)], hemoglobin [FIG. 3 (C)], and hemocyanin (not shown) are formed. When viewed electronically, the porphyrin ring is an electron acceptor, and a metal such as Mg, Fe, or Cu is an electron donor, and the electron acceptor and the electron donor coexist in the same molecule. However, also in this case, the above effect is sufficiently realized. This is because the electron donor does not react to the negative electricity on the skin surface in the area where the electron donor comes into contact with the skin, so the above effect can be obtained if the electron acceptor comes into contact with the skin. Is. Therefore, any compound having an electron accepting structure in the molecule may coexist with a compound having an electron donating structure.

【0007】この接触治療剤の用法としては、導電性の
あるプラスチックに練り込みプラスターで貼る方法、塗
り薬に入れる方法、パップ剤に入れる方法、クリームに
入れる方法、パック剤に入れる方法、リンスに入れる方
法、ヘヤリキッドやポマードに入れる方法、入浴剤に入
れる方法などが可能であり、幅広く用いることができ
る。
This contact therapeutic agent can be used by kneading it in a conductive plastic and applying it with plaster, applying it in a patch, putting it in a poultice, putting it in a cream, putting it in a pack, or putting it in a rinse. The method, the method of putting it in a hair liquid or pomade, the method of putting it in a bathing agent and the like are possible and can be widely used.

【0008】[0008]

【作用】分子内に電子受容構造を有する化合物は、電子
を誘引し、正電荷を反撥する性質を持っている。通常、
人間の表皮の表側は負に裏側は正に分極していて、数十
ミリボルトの電位差があり、これが大きくなると痛みの
原因となる。鍼治療の場合は、鍼を皮下まで刺入すると
皮膚の表面と裏面が電気的に短絡するため、異常電位が
解消して痛みが無くなるといわれる。分子内に電子受容
構造を有する化合物を皮膚の異常電位を起こしている箇
所に接触させると、負の電気(電子)を引きつけ、表面
の異常電位が解消される。表面の異常電位が解消される
と、表皮を間に誘電関係にある裏電位も正常に戻り、異
常電位に伴う筋肉痛も解消され筋肉は活性化される。負
の電気を吸収した電子受容構造を有する化合物は、時間
を経て被服等に放電して元に戻る。
[Function] A compound having an electron-accepting structure in the molecule has a property of attracting an electron and repelling a positive charge. Normal,
The front side of the human epidermis is negatively polarized and the back side is positively polarized, and there is a potential difference of several tens of millivolts, and when this becomes large, it causes pain. In the case of acupuncture, it is said that when an acupuncture needle is inserted under the skin, the front surface and the back surface of the skin are electrically short-circuited, so that the abnormal potential disappears and the pain disappears. When a compound having an electron-accepting structure in the molecule is brought into contact with a portion of the skin where an abnormal electric potential is generated, negative electricity (electrons) is attracted to eliminate the abnormal electric potential on the surface. When the abnormal potential on the surface is eliminated, the back potential, which has a dielectric relationship between the epidermis, returns to normal, and the muscle pain associated with the abnormal potential is eliminated and the muscle is activated. A compound having an electron-accepting structure that absorbs negative electricity is discharged to clothes or the like and returns to the original state with time.

【0009】分子内に電子受容構造を有する化合物のも
う一つの作用として、血流の増加がある。末端組織に酸
素及び栄養分を供給した血液は、炭酸ガスと老廃物を溶
解して静脈から心臓へ戻る。このとき、静脈は脈動によ
り血液を送っており、電子受容構造を有する化合物は静
脈の脈動を活性化し、筋肉の老化を防止する。一般に凝
りや皺、脱毛などは、皮膚内部の血流の減少や皮膚の保
水性の減退など、老化に起因するものと見られており、
電子受容構造を有する化合物を用いて皮膚内部の活性化
を行うことにより、筋肉痛、肩凝り、皺取り、育毛など
に卓効が得られる。
Another action of the compound having an electron accepting structure in the molecule is to increase blood flow. Blood that supplies oxygen and nutrients to the terminal tissues dissolves carbon dioxide and waste products and returns from the veins to the heart. At this time, the veins send blood by pulsation, and the compound having an electron accepting structure activates the pulsation of the veins and prevents muscle aging. Generally, stiffness, wrinkles, hair loss, etc. are considered to be caused by aging, such as a decrease in blood flow inside the skin and a decrease in water retention of the skin.
By activating the inside of the skin using a compound having an electron-accepting structure, excellent effects can be obtained in muscle pain, stiff shoulder, wrinkle removal, hair growth and the like.

【0010】[0010]

【実施例】【Example】

(実施例1)食品添加用銅クロロフィリンナトリウム
0.2gを、資生堂製エリクシールトリートメントマス
ク20gに練り込み、市販の救急絆創膏の布地に塗って
乾燥した。これを腕の上がらない重症の肩凝り患者4
名、中等症肩凝り患者5名の肩井、巨骨、曲垣、天宗、
中府、雲門の各経絡に毎日入浴後貼付した。1週間経過
後重症患者2名全快、1名80%回復、1名はやや改
善、中等症患者3名全快、1名80%回復、1名50%
回復となり、効果率は79%であった。
(Example 1) 0.2 g of copper chlorophyllin sodium for food additives was kneaded into 20 g of Shiseido's Elixir treatment mask, applied to a commercially available first-aid bandage fabric, and dried. Severe shoulder stiffness patient 4 who does not raise this arm
Name, shoulders of 5 patients with moderate stiff shoulder, big bones, Magaki, Tenmune,
It was attached to each meridian of Chufu and Kumon after bathing every day. After 1 week, all the severely ill patients were completely relieved, 80% recovered in 1 person, 1 was slightly improved, 3 in moderately ill patients were recovered, 80% recovered in 1 person, 50% in 1 person
It was recovered and the effect rate was 79%.

【0011】(実施例2)P−ベンゾキノン0.2gを
エポキシ樹脂20gに練り込み、径約5mmの半球状に常
温固化させた。これを径約5mmの丸型プラスターで重症
腰痛患者3名、中等症腰痛患者5名に対し、承山、腎
兪、志室、大腸兪、関元兪の各経絡の圧痛点に貼付し
た。3日間貼付後一度取り、1日おいて再び3日間貼付
した。重症患者2名全快、1名不変、中等症患者3名全
快、1名80%回復、1名やや回復となり、効果率は7
3%であった。
(Example 2) 0.2 g of P-benzoquinone was kneaded into 20 g of epoxy resin and solidified at room temperature into a hemisphere having a diameter of about 5 mm. A round plaster with a diameter of about 5 mm was applied to the tender points of each meridian of Jojo, Renyu, Shimuro, Colon Yu and Seki Motoyu for 3 patients with severe low back pain and 5 patients with moderate low back pain. After sticking for 3 days, it was taken once, left one day, and stuck again for 3 days. 2 severely ill patients, 1 unchanged, 3 moderately ill patients, 1% 80% recovery, 1 slightly recovery, 7 effective rate
It was 3%.

【0012】(実施例3)食品添加用銅クロロフィリン
ナトリウム0.2gを、花王製ソフィーナモイスチュア
パック70gに溶解した。このパック剤を女性5名でパ
ックしたところ、目尻の下の皺が取れた者3名、額の皺
が取れた者1名であった。 (実施例4)銅フタロシアニン0.1gを、資生堂製エ
リクシールトリートメントマスク20gに混ぜよく練り
合わせてから、腕の痛む患者3名の手三里、曲池、極
泉、孔最、湯溜、尺沢の各経絡に入浴後塗布した。6日
後2名はほぼ全快、1名は50%回復となった。
Example 3 0.2 g of copper chlorophyllin sodium for food addition was dissolved in 70 g of Sophina Moisture Pack manufactured by Kao. When this pack was packed by 5 women, 3 wrinkled under the corners of the eyes and 1 wrinkled on the forehead. (Example 4) After 0.1 g of copper phthalocyanine was mixed with 20 g of Shiseido's Elixir treatment mask and kneaded well, the three patients with arm pain, Tezuri, Kageike, Gokusen, Kosai, Yudama and Shakusawa Each meridian was applied after bathing. Six days later, the two had almost recovered, and the other one had a 50% recovery.

【0013】(実施例5)食品添加用銅クロロフィリン
ナトリウム0.5gを、容量約1tの風呂に添加し、腰
痛患者1名、神経痛患者1名が約1月入浴した。経過は
良好でほぼ軽快した。 (実施例6)フラン0.5gを、柳屋ヘアトニック20
gに混合し、育毛剤として使用した。やや薄毛1名は約
1月後、他の1名は1.5月後、増毛し始めた。
(Example 5) 0.5 g of copper chlorophyllin sodium for food addition was added to a bath having a capacity of about 1 t, and one back pain patient and one neuralgia patient took a bath for about one month. The progress was good and almost improved. (Example 6) 0.5 g of furan was added to Yanagiya Hair Tonic 20.
It was mixed with g and used as a hair restorer. One slightly thinning hair started to grow in about one month, and the other one started growing in 1.5 months.

【0014】[0014]

【発明の効果】以上説明したように、本発明の接触治療
剤は、分子内に電子受容構造を有する化合物を使用する
ため効果が良く、筋肉痛、肩こり等の治療に加え、皺と
り、育毛などにも有効である。また、幅広く様々な方法
で使用できる。
As described above, the contact therapeutic agent of the present invention has a good effect because it uses a compound having an electron-accepting structure in the molecule. In addition to the treatment of muscle soreness, stiff shoulders, etc., wrinkle removal and hair growth It is also effective for It can also be used in a wide variety of ways.

【図面の簡単な説明】[Brief description of drawings]

【図1】(A)オルト−ベンゾキノンの構造式を示す図
である。 (B)パラ−ベンゾキノンの構造式を示す図である。
FIG. 1 is a diagram showing a structural formula of (A) ortho-benzoquinone. It is a figure which shows the structural formula of (B) para-benzoquinone.

【図2】(A)フランの構造式を示す図である。 (B)フルフラールの構造式を示す図である。 (C)ピロールの構造式を示す図である。 (D)チオフェンの構造式を示す図である。 (E)フタロシアニン環の構造式を示す図である。 (F)フタロシアニンブルーの構造式を示す図である。FIG. 2 is a diagram showing the structural formula of (A) furan. It is a figure which shows the structural formula of (B) furfural. It is a figure which shows the structural formula of (C) pyrrole. It is a figure which shows the structural formula of (D) thiophene. It is a figure which shows the structural formula of (E) phthalocyanine ring. It is a figure which shows the structural formula of (F) phthalocyanine blue.

【図3】(A)ポルフィリン環の構造式を示す図であ
る。 (B)クロロフィルAの構造式を示す図である。 (C)ヘモグロビンの構造式を示す図である。
FIG. 3 is a diagram showing a structural formula of a porphyrin ring (A). It is a figure which shows the structural formula of (B) chlorophyll A. It is a figure which shows the structural formula of (C) hemoglobin.

フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/40 ADA 7252−4C 31/555 7252−4C C07D 307/28 307/48 333/10 Front page continuation (51) Int.Cl. 5 Identification code Office reference number FI Technical display location A61K 31/40 ADA 7252-4C 31/555 7252-4C C07D 307/28 307/48 333/10

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 人体の皮膚表面に接触可能で、分子内に
電子受容構造を有する化合物からなる接触治療剤。
1. A contact therapeutic agent comprising a compound capable of contacting the skin surface of a human body and having an electron accepting structure in the molecule.
【請求項2】 分子内に電子受容構造を有する化合物
が、キノン、フラン、フルフラール、ピロール、チオフ
ェン、フタロシアニン、又は、それらの誘導体である請
求項1記載の接触治療剤。
2. The therapeutic agent for contact according to claim 1, wherein the compound having an electron accepting structure in the molecule is quinone, furan, furfural, pyrrole, thiophene, phthalocyanine, or a derivative thereof.
【請求項3】 分子内に電子受容構造を有する化合物
が、クロロフィル、ヘモグロビン、ヘモシアニン、又
は、それらの誘導体である請求項1記載の接触治療剤。
3. The contact therapeutic agent according to claim 1, wherein the compound having an electron accepting structure in the molecule is chlorophyll, hemoglobin, hemocyanin, or a derivative thereof.
JP4111835A 1992-04-30 1992-04-30 Pain remedy Expired - Fee Related JP2540691B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4111835A JP2540691B2 (en) 1992-04-30 1992-04-30 Pain remedy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4111835A JP2540691B2 (en) 1992-04-30 1992-04-30 Pain remedy

Publications (2)

Publication Number Publication Date
JPH05310597A true JPH05310597A (en) 1993-11-22
JP2540691B2 JP2540691B2 (en) 1996-10-09

Family

ID=14571369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4111835A Expired - Fee Related JP2540691B2 (en) 1992-04-30 1992-04-30 Pain remedy

Country Status (1)

Country Link
JP (1) JP2540691B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034970A1 (en) * 2000-07-19 2002-02-07 Sanguibio Tech Ag An oxygen carrier selected from hemoglobin or hemoglobin and myoglobin-containing preparation in the form of an emulsion as a cosmetic external and for the natural regeneration of the skin in the case of oxygen deficiency
FR2835182A1 (en) * 2002-01-31 2003-08-01 Oreal USE OF THIOPHENES TO BODY HUMAN KERATINIC FIBERS
US7217295B2 (en) 2002-01-31 2007-05-15 L'oreal S.A. Use of soluble conductive polymers for treating human keratin fibers
JP2014043400A (en) * 2012-08-24 2014-03-13 Naris Cosmetics Co Ltd Wrinkle improvement agent
WO2022114111A1 (en) * 2020-11-27 2022-06-02 マルホ株式会社 Pharmaceutical or cosmetic composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226219A (en) * 1985-07-25 1987-02-04 Shiseido Co Ltd External drug for skin
JPH049330A (en) * 1990-04-26 1992-01-14 Nippon Oil & Fats Co Ltd Anti-trichophyte agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226219A (en) * 1985-07-25 1987-02-04 Shiseido Co Ltd External drug for skin
JPH049330A (en) * 1990-04-26 1992-01-14 Nippon Oil & Fats Co Ltd Anti-trichophyte agent

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034970A1 (en) * 2000-07-19 2002-02-07 Sanguibio Tech Ag An oxygen carrier selected from hemoglobin or hemoglobin and myoglobin-containing preparation in the form of an emulsion as a cosmetic external and for the natural regeneration of the skin in the case of oxygen deficiency
DE10034970B4 (en) * 2000-07-19 2004-11-18 Sanguibiotech Gmbh An oxygen carrier, selected from hemoglobin or a preparation containing hemoglobin and myoglobin in the form of an emulsion, and its use as a cosmetic external and for the natural regeneration of the skin in the absence of oxygen
FR2835182A1 (en) * 2002-01-31 2003-08-01 Oreal USE OF THIOPHENES TO BODY HUMAN KERATINIC FIBERS
US7217295B2 (en) 2002-01-31 2007-05-15 L'oreal S.A. Use of soluble conductive polymers for treating human keratin fibers
JP2014043400A (en) * 2012-08-24 2014-03-13 Naris Cosmetics Co Ltd Wrinkle improvement agent
WO2022114111A1 (en) * 2020-11-27 2022-06-02 マルホ株式会社 Pharmaceutical or cosmetic composition

Also Published As

Publication number Publication date
JP2540691B2 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
US20030144625A1 (en) Method and apparatus for the treatment of infections of the nail matrix and nail plate
JPH05310597A (en) Agent for contact treatment
Omura Storing of Qi Gong energy in various materials and drugs (Qi Gongnization): its clinical application for treatment of pain, circulatory disturbance, bacterial or viral infections, heavy metal deposits, and related intractable medical problems by selectively enhancing circulation and drug uptake
JP2572520B2 (en) Semiconductor therapeutics
Glickman et al. Psoriatic angiogenic factor: evidence for its existence
Clarkson et al. Two cases of basal-cell congenital naevus
RU2321397C2 (en) Composition for vitiligo treatment
RU2132187C1 (en) Method and magnetic active organic iron compound for treating skin and mucosa disease
JPS5838566A (en) Special treating device
Cowen Electricity in gynaecology
Martin-Scott Alopecia mucinosa (Pinkus).
Swinburne THE USE OF ARGYROL IN THE TREATMENT OF ACUTE GONORRHCEA
SU1397042A1 (en) Method of treatment of prostatitis
JPH03227937A (en) Remedy and preventive agent of dermal disease
SU889012A1 (en) Method of treating chronic and near-acute vessel deseases and peripheral nerve deseases
Levick ELECTRICAL TREATMENT OF MUSCLES IN “TRENCH FEET.”
Hardaway et al. Handbook of Cutaneous Therapeutics: Including Sections on the X-ray, High-frequency Current and the Minor Surgery of the Skin, for the Use of General Practitioners
Jordan A Case of Lymphatic Fistula Following Excision of Tuberculous Lymphatic Glands: Cure
RU2128971C1 (en) Device for protection against pregnancy
Kligman et al. Inactivity of corticosteroids on elastotic tissue
BR102018071761A2 (en) process for obtaining healing ointment
Reilly Acne Vulgaris
SNOW et al. AMERICAN JOURNAL OF ELECTROTHERAPEUTICS AND RADIOLOGY OFFICIAL ORGAN OF THE AMERICAN ELECTROTHERAPEUTIC ASSOCIATION AND
Rockwell Clinical researhes in electro-surgery
DICKSON Society Reports

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19960409

LAPS Cancellation because of no payment of annual fees